期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 246, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2022.115028
关键词
Histone methyltransferases; Cysteine modification; Covalent inhibitors; Discovery strategy
Post-translational methylation of histone lysine or arginine residues by histone methyltransferases (HMTs) is crucial for gene regulation and physiological processes, and is implicated in human diseases. Histone methyltransferases are potential therapeutic targets and the development of inhibitors has been pursued over the past decade. Covalent inhibitors for HMTs have gained increasing attention and this review focuses on their discovery, characterization, and applications, as well as challenges and future directions in drug discovery.
Post-translational methylation of histone lysine or arginine residues by histone methyltransferases (HMTs) plays crucial roles in gene regulation and diverse physiological processes and is implicated in a plethora of human diseases, especially cancer. Therefore, histone methyltransferases have been increasingly recognized as potential therapeutic targets. Consequently, the discovery and development of histone methyltransferase inhibitors have been pursued with steadily increasing interest over the past decade. However, the disadvantages of limited clinical efficacy, moderate selectivity, and propensity for acquired resistance have hindered the development of HMTs inhibitors. Targeted covalent modification represents a proven strategy for kinase drug development and has gained increasing attention in HMTs drug discovery. In this review, we focus on the discovery, character-ization, and biological applications of covalent inhibitors for HMTs with emphasis on advancements in the field. In addition, we identify the challenges and future directions in this fast-growing research area of drug discovery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据